What does the NVVC stand for?
The NVVC unites cardiologists around four themes: quality, education, science & innovation and professional interests. We strive to enable high-quality cardiological care through proper education and training, implementation of guidelines, quality inspections, quality registrations, and through research and innovation, especially research concentrated at evaluation of care.
What does the NVVC hope to get out of the partnership with the DCVA?
As a partner of the DCVA, the NVVC hopes to facilitate the implementation of results from scientific research. The NVVC knows the way along which promising cardiological care becomes part of daily clinical practice. In addition, due to the contact with cardiologists and patients, the NVVC is aware of knowledge that’s missing in diagnostics and treatment modalities of various cardiovascular diseases. We recently published the NVVC Knowledge Agenda, which describes eleven of such knowledge gaps, which can form the basis for scientific research. The DCVA is indispensable for the NVVC because these knowledge gaps can be investigated in DCVA-consortia. Cooperation with DCVA-partners on research themes and fundraising for research offers huge opportunities.
What does the NVVC add to the DCVA, why should we be happy that the NVVC is participating? Who ultimately benefits the most?
The NVVC has the organization to achieve the ambitions of the DCVA. Without relevant research questions raised from clinical practice and implementation of results from DCVA-research, the target to reduce cardiovascular diseases with 25% by 2030 will not be achieved. NVVC forms the link between science and patient care, has the appropriate organizational component in NVVC-Connect for implementation and thus ensures that the patient benefits the most.
Question from 4TU:
I would like to invite the NVVC to really see us, as knowledge institutions, as partners. Historically, there has often been a separation between the medical and technical worlds. In view of the increase in technical equipment within hospitals and, for example, software-based solutions such as artificial intelligence, it is important that the medical and technical worlds collaborate. The Netherlands is a small country; we know each other well. Let’s unite to make the Netherlands a pioneer in the prevention, diagnosis and treatment of cardiovascular diseases. The question then is: shall we organize a joint meeting where 4TU presents relevant research and where the NVVC indicates the challenges. The aim would be to jointly define new common goals. What do you think of that and why?
Of course, we would appreciate such a joint discussion. As a guideline, we can introduce our recently published Knowledge Agenda, which includes eleven knowledge gaps. A number of them, and perhaps all eleven, could form a starting point for setting common goals. In addition, software solutions and e-health can help us to improve care for our patients.